Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios G Oreopoulos

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
International Urology and Nephrology|July 27, 2006
Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease?Mingxin Wei, Khaled Esbaei, Joanne M Bargman, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 7, 2002
Normal or low initial PTH levels are not a predictor of morbidity/mortality in patients undergoing chronic peritoneal dialysisNada B Dimkovic, Joanne Bargman, Stephen Vas, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 19, 2009
Association between pulse pressure and mortality in patients undergoing peritoneal dialysisWei Fang, Xiao Yang, Joanne M Bargman, et al.
Journal of Nephrology|October 6, 2007
Physiological similarities and differences between renal aging and chronic renal diseaseCarlos G Musso, Juan F Macías Nuñez, Dimitrios G Oreopoulos
International Urology and Nephrology|September 6, 2005
Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: will new dialysis solutions prevent these changes?Murali Krishnan, Paul Tam, George Wu, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 16, 2006
Correlation between fractional reabsorption of sodium and erythropoietin dose in peritoneal dialysis patientsShahrzad Ossareh, Iloise Moupas, Elias Thodis, et al.
International Urology and Nephrology|March 4, 2009
Prolonged use of the tyrosine kinase inhibitor in a peritoneal dialysis patient with metastatic renal cell carcinoma: possible beneficial effects on peritoneal membrane and peritonitis ratesShruti N Tapiawala, Joanne M Bargman, Dimitrios G Oreopoulos, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 6, 2006
Iron sucrose induced morphological and functional changes in the rat kidneyAndrzej Breborowicz, Alicja Polubinska, Kinga Górna, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 9, 2026
The Eighth Question of AI in IRBryan Buckley, Sabreena Moosa, Dimitrios G Oreopoulos, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 22, 2009
Peritoneal equilibration testing: correcting the correction factorPaul Tam, Petra Sheldrake, Anita Ng, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
International Urology and Nephrology|July 27, 2006
Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease?Mingxin Wei, Khaled Esbaei, Joanne M Bargman, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 7, 2002
Normal or low initial PTH levels are not a predictor of morbidity/mortality in patients undergoing chronic peritoneal dialysisNada B Dimkovic, Joanne Bargman, Stephen Vas, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 19, 2009
Association between pulse pressure and mortality in patients undergoing peritoneal dialysisWei Fang, Xiao Yang, Joanne M Bargman, et al.
Journal of Nephrology|October 6, 2007
Physiological similarities and differences between renal aging and chronic renal diseaseCarlos G Musso, Juan F Macías Nuñez, Dimitrios G Oreopoulos
International Urology and Nephrology|September 6, 2005
Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: will new dialysis solutions prevent these changes?Murali Krishnan, Paul Tam, George Wu, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 16, 2006
Correlation between fractional reabsorption of sodium and erythropoietin dose in peritoneal dialysis patientsShahrzad Ossareh, Iloise Moupas, Elias Thodis, et al.
International Urology and Nephrology|March 4, 2009
Prolonged use of the tyrosine kinase inhibitor in a peritoneal dialysis patient with metastatic renal cell carcinoma: possible beneficial effects on peritoneal membrane and peritonitis ratesShruti N Tapiawala, Joanne M Bargman, Dimitrios G Oreopoulos, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 6, 2006
Iron sucrose induced morphological and functional changes in the rat kidneyAndrzej Breborowicz, Alicja Polubinska, Kinga Górna, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 9, 2026
The Eighth Question of AI in IRBryan Buckley, Sabreena Moosa, Dimitrios G Oreopoulos, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 22, 2009
Peritoneal equilibration testing: correcting the correction factorPaul Tam, Petra Sheldrake, Anita Ng, et al.
Pageof 11